Literature DB >> 34013858

Reflections on 40 Years of AIDS.

Kevin M De Cock, Harold W Jaffe, James W Curran.   

Abstract

June 2021 marks the 40th anniversary of the first description of AIDS. On the 30th anniversary, we defined priorities as improving use of existing interventions, clarifying optimal use of HIV testing and antiretroviral therapy for prevention and treatment, continuing research, and ensuring sustainability of the response. Despite scientific and programmatic progress, the end of AIDS is not in sight. Other major epidemics over the past decade have included Ebola, arbovirus infections, and coronavirus disease (COVID-19). A benchmark against which to compare other global interventions is the HIV/AIDS response in terms of funding, coordination, and solidarity. Lessons from Ebola and HIV/AIDS are pertinent to the COVID-19 response. The fifth decade of AIDS will have to position HIV/AIDS in the context of enhanced preparedness and capacity to respond to other potential pandemics and transnational health threats.

Entities:  

Keywords:  AIDS; COVID-19; Ebola; HIV; HIV/AIDS; SDGs; acquired immune deficiency syndrome; coronavirus disease; forty years; health security; history; human immunodeficiency virus

Year:  2021        PMID: 34013858     DOI: 10.3201/eid2706.210284

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  9 in total

1.  World AIDS Day 2021: highlighting the pulmonary complications of HIV/AIDS.

Authors:  Rory E Morty; Alison Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-11-24       Impact factor: 6.011

Review 2.  The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance.

Authors:  Daisy Yan; One Hyuk Ra; Bingfang Yan
Journal:  Anim Dis       Date:  2021-09-07

3.  HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis.

Authors:  Abdur Rashid; Kang Li; Yi Feng; Tauseef Ahmad; Yimam Getaneh; Yueyang Yu; Xiaoyan Hu; Syed Hani Abidi; Yiming Shao
Journal:  Hum Vaccin Immunother       Date:  2022-01-11       Impact factor: 3.452

Review 4.  Intersecting Pandemics of HIV and SARS-CoV-2: Commentary on the Special Issue.

Authors:  Sten H Vermund
Journal:  Curr HIV/AIDS Rep       Date:  2022-02       Impact factor: 5.495

Review 5.  Saquinavir: From HIV to COVID-19 and Cancer Treatment.

Authors:  Mariana Pereira; Nuno Vale
Journal:  Biomolecules       Date:  2022-07-05

6.  Study on the Mechanism of Improving HIV/AIDS Immune Function with Jian Aikang Concentrated Pill Based on Network Pharmacology Combined with Experimental Validation.

Authors:  Cancan Shao; Haojie Wang; Feng Sang; Liran Xu
Journal:  Drug Des Devel Ther       Date:  2022-08-18       Impact factor: 4.319

7.  Synthesis, Biological Evaluation, and Molecular Modeling Studies of New 8-methyl-4-oxo-1,4-dihydroquinoline-3-carbohydrazides as Potential Anti-HIV Agents.

Authors:  Mehrdad Alemi; Fatemeh Kamali; Rouhollah Vahabpour Roudsari; Zahra Hajimahdi; Afshin Zarghi
Journal:  Iran J Pharm Res       Date:  2022-05-17       Impact factor: 1.962

8.  HIV Knowledge and Stigmatizing Attitude towards People Living with HIV/AIDS among Medical Students in Jordan.

Authors:  Malik Sallam; Ali M Alabbadi; Sarah Abdel-Razeq; Kareem Battah; Leen Malkawi; Mousa A Al-Abbadi; Azmi Mahafzah
Journal:  Int J Environ Res Public Health       Date:  2022-01-10       Impact factor: 3.390

9.  Ultra-long-acting (XLA) antivirals for chronic viral hepatitis.

Authors:  Vicente Soriano; Carmen Alvarez; Benson Edagwa; Carmen de Mendoza; Noemí Montoya; Ana Treviño; Howard Gendelman
Journal:  Int J Infect Dis       Date:  2021-10-30       Impact factor: 12.074

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.